Is there a clinically significant drug‑drug interaction between semaglutide (GLP‑1 receptor agonist) and lamotrigine (Lamictal)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 2, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Semaglutide and Lamotrigine (Lamictal) Interaction

There is no clinically significant drug-drug interaction between semaglutide and lamotrigine. You can safely prescribe these medications together without dose adjustments.

Pharmacokinetic Evidence

Semaglutide does not affect the absorption, metabolism, or elimination of concomitant oral medications. In a dedicated drug-interaction study, semaglutide 1.0 mg weekly was co-administered with multiple oral agents (metformin, warfarin, atorvastatin, and digoxin), and the area under the plasma concentration-time curve ratios for all medications remained within the pre-specified no-interaction interval of 0.80–1.25 1. This demonstrates that semaglutide does not alter the pharmacokinetics of oral drugs to a clinically relevant degree 1.

The mechanism of semaglutide—GLP-1 receptor activation—does not involve cytochrome P450 enzymes or drug transporters that would interact with lamotrigine. Semaglutide undergoes minimal metabolism and renal excretion due to its structural modifications (amino acid substitutions and fatty acid conjugation), resulting in negligible enzyme- or transporter-mediated drug interactions 2. Lamotrigine is primarily metabolized by glucuronidation (UGT1A4), a pathway entirely separate from semaglutide's mechanism 2.

Gastric Emptying Considerations

Although semaglutide delays gastric emptying, this does not produce clinically meaningful changes in lamotrigine absorption. The delayed gastric emptying caused by semaglutide (through inhibition of gastric peristalsis and increased pyloric tone) 3 theoretically could affect oral drug absorption. However, the drug-interaction study showed no clinically significant impact on maximum plasma concentrations of co-administered medications 1.

Lamotrigine has a wide therapeutic index and predictable absorption kinetics, making it resistant to gastric-emptying effects. Unlike narrow-therapeutic-index drugs (e.g., warfarin, levothyroxine) where even modest absorption changes matter, lamotrigine's dosing flexibility and broad safety margin mean that any minor delay in absorption would not affect seizure control or mood stabilization 1, 2.

Practical Clinical Guidance

No dose adjustment of lamotrigine is required when initiating, titrating, or maintaining semaglutide. Continue the patient's established lamotrigine regimen without modification 1.

No additional monitoring beyond standard lamotrigine therapeutic drug monitoring is necessary. If the patient is on a stable lamotrigine dose with good seizure control or mood stability, adding semaglutide will not disrupt this 1.

The 30-minute fasting requirement for oral semaglutide does not apply to lamotrigine timing. If the patient is prescribed oral semaglutide (rather than injectable), they should take oral semaglutide first thing in the morning with ≤4 oz water, wait 30 minutes, then take lamotrigine with their usual morning medications 2. For injectable semaglutide (weekly), there are no timing restrictions with lamotrigine 1.

Common Pitfalls to Avoid

Do not unnecessarily hold or reduce lamotrigine when starting semaglutide. There is no pharmacologic rationale for this, and it risks breakthrough seizures or mood destabilization 1.

Do not attribute new gastrointestinal symptoms to a drug interaction. Nausea, vomiting, and diarrhea occur in 17–44% of patients starting semaglutide due to the drug's mechanism of action (delayed gastric emptying and central appetite suppression), not because of an interaction with lamotrigine 4, 3.

Do not confuse semaglutide's lack of CYP450 interactions with other diabetes medications. Unlike some oral antidiabetic agents, semaglutide has a clean interaction profile because it is a peptide analog that bypasses hepatic metabolism 2.

Summary Algorithm

  1. Patient on stable lamotrigine + considering semaglutide? → Prescribe semaglutide at standard doses without lamotrigine adjustment 1.
  2. Patient on semaglutide + needs lamotrigine initiated? → Titrate lamotrigine per standard protocols (no interaction concerns) 1.
  3. Patient reports new symptoms after starting both? → Attribute gastrointestinal effects to semaglutide (expected), not drug interaction 4, 3.
  4. Monitoring required? → Only standard lamotrigine monitoring (no additional labs for interaction) 1.

References

3
Guideline

Semaglutide Mechanism and Efficacy in Insulin Resistance

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4
Guideline

Pharmacological Management of Obesity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the equivalent dose of subcutaneous semaglutide (GLP-1 receptor agonist) for a patient taking 7mg of oral semaglutide?
Are there any significant drug interactions or safety concerns with the combination of semaglutide, nustenci, esomeprazole, citalopram 20 mg, atorvastatin 10–20 mg, enalapril, selozok 50 mg, and cifrar ex 5 mg twice daily?
What is the best treatment approach for an elderly female patient with uncontrolled hyperglycemia, currently taking Metformin (biguanide) 1000mg once daily and Ozempic (semaglutide) 0.5mg once weekly?
Are there any interactions between GLP-1 (Glucagon-like peptide-1) receptor agonists, SSRIs (Selective Serotonin Reuptake Inhibitors), and ADHD (Attention Deficit Hyperactivity Disorder) medications?
How should I adjust the diabetes regimen for a 79‑year‑old man with type 2 diabetes on semaglutide 2 mg weekly, a sulfonylurea 5 mg twice daily, and another oral agent 45 mg, who has random glucose of 65 mg/dL then 173 mg/dL with a normal anion gap and HbA1c 7%?
What are the likely etiologies and management for pruritus ani that begins or worsens after showering?
What is the appropriate prescription for Lomotil (diphenoxylate 2.5 mg/atropine 0.025 mg) at the lowest effective adult dose for an adult patient with three days of watery diarrhea, assuming no allergies, not pregnant, and no severe hepatic impairment, including dosing schedule and follow‑up instructions?
Is amikacin more ototoxic than tobramycin or gentamicin?
Why do EMS providers perform medication‑free (crash) intubation in patients who cannot protect their airway, are apneic, severely hypoxic, or are in cardiac arrest, severe traumatic brain injury, major trauma with suspected cervical spine injury, massive hemorrhage, or drug overdose?
Is sodium oxybate (Xyrem) a ketone, and does it cause the body to produce ketone bodies?
Is it appropriate to take the lisinopril (ACE inhibitor) and hydrochlorothiazide (thiazide diuretic) combination twice daily (bid)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question